MATTHEW FRYZEK: Open Payments
NPI 1417020595 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,455 in 140 payments from 31 companies in 2025. Trend: 2023 $3,894 · 2024 $2,914 · 2025 $3,455
Food & beverage: $3,455
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $521 |
| E.R. Squibb & Sons, L.L.C. | 8 | $333 |
| Novo Nordisk Inc | 13 | $309 |
| Axsome Therapeutics, Inc. | 3 | $254 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $199 |
| Novartis Pharmaceuticals Corporation | 11 | $192 |
| PFIZER INC. | 11 | $175 |
| Amgen Inc. | 13 | $163 |
| ABBVIE INC. | 9 | $160 |
| Lilly USA, LLC | 9 | $140 |
Products named: Auvelity, Ozempic, BREZTRI, Kerendia, LEQVIO, CAMZYOS, FARXIGA, AIRSUPRA.
Industry payments across IA — which companies pay providers there.
